Amrutanjan Health Care Quarterly Results for Trading Insights
AMRUTANJAN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹21 Cr
QMarch 2016
Amrutanjan Health Care Quarterly Results Key Highlights
- Revenue of ₹192 Cr in March 2016 (+0.0% vs March 2016, +12.3% vs March 2015)
- Net Profit of ₹21 Cr in March 2016 (+0.0% vs March 2016, +40.0% vs March 2015)
- EBITDA of ₹37 Cr in March 2016 (+0.0% vs March 2016)
- Operating Margin of 16.0% in March 2016 (+0.0pp vs March 2016)
- Earnings Per Share of ₹14.08 in March 2016 (+0.0% vs March 2016)
Amrutanjan Health Care Quarterly Results Analysis
| Metric | 2026 | March 2016 | March 2015 | QoQ | YoY |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 192 | 171 | - | - |
| Net Profit (₹ Cr) | 0 | 21 | 15 | - | - |
| EBITDA (₹ Cr) | 0 | 37 | 28 | - | - |
| EPS (₹) | 0.00 | 14.08 | 10.31 | - | - |
| Operating Margin (%) | 0.0% | 16.0% | 14.0% | - | - |
Amrutanjan Health Care Share Price Trend Around Quarterly Results
Visualize Amrutanjan Health Care's 1-year price movement across quarterly results — ideal for logging trades in Amrutanjan Health Care share price
chart using Tickjournal. All values in ₹.
Related Pages for Amrutanjan Health Care
Additional stock information and data for AMRUTANJAN
Revenue Trend (₹ Cr)
March 2015
171
March 2016
192
2026
0
Net Profit Trend (₹ Cr)
March 2015
15
March 2016
21
2026
0
Operating Margin Trend (%)
March 2015
14.0%
March 2016
16.0%
2026
0.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Amrutanjan Health Care quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹391,547.47 Cr | 1627.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 125.2 |
|
Divis Laboratories
Sept 2025 |
₹160,887.23 Cr | 5952.5 | 2,860 | 689 | +7.1% | - | 24.1% | 229.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,071.99 Cr | 3987.2 | 3,219 | 591 | +11.3% | - | 18.4% | 227.3 |
|
Cipla
Sept 2025 |
₹110,697.00 Cr | 1311.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 78.4 |
|
Dr Reddys Laborator…
Sept 2025 |
₹103,126.93 Cr | 1182.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 73.1 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores